Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders

Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Zepbound® (tirzepatide) KwikPen® for single-patient use available from Lilly at $449 across all doses through the Lilly Employer Connect platform, with reduced cost-share pricing available to employees

Flexible benefit designs expand access to obesity treatment while aligning with employer needs and budgets

Recommended for you